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Abstract
Background: The relationship between body mass index (BMI) and end-stage renal disease (ESRD) may differ
between blacks and whites due to underlying metabolic differences.
Methods: We conducted a nested case–control study of 631 incident ESRD cases and 1,897 matched controls
within the Southern Community Cohort Study. Current weight, height, and weight at age 21 were reported at
enrollment. Occurrence of ESRD was ascertained by linkage with the United States Renal Data System. With normal
BMI (18.5–24.9 kg/m2) as reference, conditional logistic regression was used to calculate adjusted odds ratios (OR)
and corresponding 95 % confidence intervals (CI) for ESRD across other BMI categories by race. In subsequent
analysis, BMI at age 21 was modeled using restricted cubic splines with 5 knots. Predicted probabilities of incident
ESRD were computed from the multivariable logistic models and plotted against BMI at age 21.
Results: Among blacks, odds of ESRD were significantly increased among those who were overweight (OR: 1.41; 95 % CI:
1.09, 1.83) or obese (OR: 2.56; 95 % CI: 1.88, 3.47) at age 21. Among whites, the association between ESRD and BMI at age
21 was more pronounced, with corresponding ORs of 2.13 (95 % CI: 0.92, 4.93) and 7.46 (95 % CI: 2.90, 19.21; p-interaction
0.05). Only among whites was high BMI at enrollment associated with ESRD risk; OR for BMI≥ 40 kg/m2, was 3.31 (95 %
CI: 1.08, 10.12). The plot of the predicted probabilities of incident ESRD vs BMI at age 21 showed a monotonic increase in
the probability of ESRD after a BMI cutoff ≈ 25Kg/m2 in both whites and blacks but the slope of the curve for whites
appeared greater.
Conclusions: Our results suggest racial differences in the relationship between BMI, both in early adulthood and middle
age, and ESRD. These findings warrant further research into understanding the underlying metabolic differences that may
explain these differences.
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Background
As the burden of end-stage renal disease (ESRD) in the
United States (US) continues to increase [1], it remains
important to understand the role of risk factors such as
body mass index (BMI), which change during the course
of life and which may interact with race to modify ESRD
risk. Previous studies have demonstrated strong and sig-
nificant associations between higher BMI in middle aged
adults (and adolescents) and ESRD, which may be ex-
plained in part by associations of obesity with inflamma-
tion, diabetes and high blood pressure, all of which are
risk factors for adverse renal outcomes [2–9]. Given
these strong associations, the rising prevalence of early
obesity [10] is likely to impact the already substantial
health burden associated with ESRD.
A substantially higher incidence of ESRD among blacks
than whites has been consistently reported, including
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among participants of the Southern Community Cohort
Study (SCCS), an ongoing prospective cohort study of
black and white adults in the southeastern US [11]. The
association persists after adjustment for socioeconomic
variables and known ESRD risk factors [12–17]. However,
to our knowledge, only one study [8], which focused on
midlife BMI, has investigated whether there may be a dif-
ferential relationship between BMI and ESRD in blacks
and whites. For any given value of BMI, whites tend to
have higher percent body fat than blacks [18], and adipos-
ity has been demonstrated to have different metabolic ef-
fects in whites and blacks [19–22].
Therefore, we investigated whether the association be-
tween BMI in both early adulthood and midlife and
ESRD is stronger among whites compared to blacks,
using a nested case–control study within the SCCS.
Methods
Design and study population
Between 2002 and 2009, the SCCS enrolled approxi-
mately 86,000 adults (over two-thirds black) aged 40–79
living in 12 southeastern states. Approximately 86 % of
participants were recruited at community health centers
(CHC), which provide primary health and preventive
care services for low-income populations [11, 23], while
the remaining 14 % were recruited via mail-based gen-
eral population sampling. Data on socioeconomic,
demographic, lifestyle, and anthropometric characteris-
tics, as well as personal medical history, were ascertained
at cohort enrollment via standardized computer-assisted
personal interviews for CHC participants, and via self-
administered mailed questionnaire for general popula-
tion participants. Detailed description of SCCS methods
has been previously published [11, 23].
The study population for the current nested case–con-
trol study was restricted to CHC-enrollees, which en-
sured that participants were of similar socioeconomic
status and had generally equal access to health care at
cohort entry regardless of race. Incident ESRD cases
were ascertained by linkage of the cohort, using date of
birth, Social Security number, and first and last name,
with the US Renal Data System (USRDS) from January
1, 2002 to September 1, 2009, the latest date for which
data were available. The USRDS registers ESRD cases
certified by a physician diagnosis and filed using a med-
ical evidence report form (to the Medicare ESRD pro-
gram) or when there is other evidence of chronic dialysis
or a kidney transplant irrespective of the glomerular fil-
tration rate (GFR) [1, 24]. SCCS participants (n = 404)
who had a diagnosis of ESRD recorded in the USRDS
prior to SCCS enrollment were excluded from our ana-
lyses. Three controls were individually matched to each
case based on age (±5-year categories), sex and race.
Therefore, the study population for the current analysis
comprised all 631 ESRD cases identified during the
study period and 1,897 matched controls; and with this
sample size we had over 82 % power to detect an odds
ratio of 1.48.
Assessment of BMI and covariates
The main exposure variable in this study is BMI, defined
as weight (kg)/height2 (m2), calculated from weight and
height self-reported by participants at cohort entry. Par-
ticipants also reported their weight at age 21. Since BMI
at age 21 can indicate long-term exposure to obesity
and, given the relatively short follow-up period (median
2.6 years, range: 0–7.2 years) of the cohort, it may be more
closely associated than current BMI with an insidious out-
come such as ESRD. BMI at age 21was thus considered
our primary exposure of interest. We categorized BMI at
age 21 using the World Health Organization (WHO) clas-
sification as: underweight: <18.5 kg/m2; normal weight:
18.5–24.9; overweight: 25.0–29.9; obese: ≥ 30.0 [24], and
for BMI at cohort entry, further divided the obese cat-
egory into class I (30.0–34.9), class II (35.0–39.9) and class
III (≥40.0).
Statistical analysis
Univariate case–control comparisons were performed
using T-tests for continuous variables and chi-square
tests for categorical variables; 2-sided p-values were pre-
sented. The Pearson’s correlation coefficient between
BMI at enrollment and BMI at age 21 was computed.
Using normal BMI as the referent, we used conditional
logistic regression to estimate odds ratios (OR) and cor-
responding 95 % CI for ESRD associated with the other
BMI categories, overall and stratified by race. We per-
formed the main analyses using BMI at age 21 and, in
separate models, considered BMI at enrollment. We in-
vestigated race × BMI interactions using a Wald test for
the race × continuous BMI interaction term. In addition
to the matching variables, covariates included in the main
analyses were education (<high school, high school/voca-
tional training/junior college, ≥college), and cigarette smok-
ing (never, former, current). Differences between the crude
and adjusted estimates were minimal but we present the
adjusted estimates. We did not include history of diabetes
or hypertension in our main models given that these may
be on the causal pathway between elevated BMI and ESRD.
However, in sensitivity analyses, we adjusted additionally
for diabetes and hypertension at baseline, in order to exam-
ine the magnitude of the association between BMI at age
21 and ESRD independent of these two main intermediates.
Also, in order to investigate the influence of short
follow-up on the BMI at enrollment-ESRD association,
we performed additional sensitivity analyses by succes-
sively excluding cases diagnosed within 12, 24 and
36 months after enrollment.
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In subsequent analysis, BMI at 21 was modeled using
restricted cubic splines with 5 equally spaced knots
chosen according to Harrell’s percentile distribution:
0.05, 0.275, 0.5, 0.725 and 0.95 corresponding to BMI
values of 17.2, 20.7, 22.9, 25.7, 33.8 kg/m2 respectively
[25]. Predicted probabilities of incident ESRD were then
computed from the multivariable logistic models and plot-
ted against BMI at 21. Given that potential outliers at the
tail ends of the distribution—BMI at 21 < 18.5 kg/m2 and
BMI > 35 kg/m2—could influence the shape of the curve,
we performed sensitivity analyses excluding persons with
these values and plotted the curves using splines with
knots placed at 20th, 40th, 60th and 80th percentiles of
BMI at age 21.
All analyses were performed using STATA (version 12.1,
Stata Corp, College Station, Texas, USA) and R version
3.1.1 (R Core Team 2014). For all analyses, p-values < 0.05
were considered statistically significant.
Ethics statement
SCCS participants provided written informed consent,
and protocols were approved by the Institutional Review
Boards of Vanderbilt University Medical Center and
Meharry Medical College.
Results
Among the 2,528 SCCS participants included in this study,
10.4 % were white and 89.6 % were black, and 45.2 % were
men. The mean age at enrollment was 53.7 years. The
BMI at enrollment and at age 21 were significantly corre-
lated (person correlation coefficient, r = 0.38, p < 0.0001),
with mean BMI at enrollment (31.2 ± 7.7 kg/m2) substan-
tially higher than mean BMI at age 21 (23.9 ± 5.5 kg/m2).
The age and sex distributions of cases and controls
were similar given the matched design. Compared with
controls, cases were more likely to be in the lowest cat-
egories of income and education and were somewhat
more likely to be current or former smokers. History of
dyslipidemia was reported more frequently by cases than
controls, as were diagnoses of diabetes (65.1 % vs 28.5 %)
or hypertension (85.7 % vs 65.5 %). Overall, these differ-
ences were similar in blacks and whites except for educa-
tion and BMI at enrollment, for which we found significant
differences between cases and controls in blacks but not in
whites (Table 1).
Association between BMI at age 21 and ESRD
Odds ratios and 95 % CI for the association between BMI
at age 21 and ESRD are presented in Table 2. Overall,
compared to persons of normal weight, overweight per-
sons had 44 % higher odds (OR: 1.44; 95 % CI 1.13, 1.85)
for ESRD, while obese subjects had an almost 3-fold
higher odds (OR: 2.88; 95 % CI 2.16, 3.83) for ESRD.
The results of the stratified analyses (Table 2) show a
similar pattern of increasing odds for ESRD with in-
creasing BMI in both blacks and whites. However, the
association was substantially stronger in whites. In
blacks, the adjusted ORs were 1.41 (95 % CI: 1.09, 1.83)
among overweight persons and 2.56 (95 % CI: 1.88, 3.47)
among obese individuals. The corresponding ORs in
whites were 2.13 (95 % CI: 0.92, 4.93) and 7.46 (95 % CI:
2.90, 19.21). The p-value for interaction in adjusted
models revealed a marginally significant effect modifica-
tion by race of the association between BMI at age 21
and ESRD (p = 0.05).
The plot of the predicted probabilities of incident
ESRD vs BMI at age 21 showed a monotonic increase in
the probability of ESRD after a BMI cutoff ≈ 25 kg/m2 in
both whites and blacks but the slope of the curve for
whites appeared greater (Fig. 1). In sensitivity analyses
excluding persons with BMI <18.5 kg/m2 and >35 kg/
m2, the curves for both blacks and whites still showed
monotonic increases in the probability of ESRD with in-
creasing BMI at age 21 and the curve for whites was
steeper than that of blacks after a BMI of ≈ 27 kg/m2
(Additional file 1) i.e. the difference in slopes appeared
greater in the region were we have the most data: BMI =
18.5–35 kg/m2.
Association between BMI at enrollment and ESRD
Overall, compared to persons of normal weight, individ-
uals who were overweight or obese at cohort enrollment
were not at increased odds of developing ESRD (Table 3).
In analyses stratified by race, being overweight (OR: 0.81;
95 % CI: 0.61, 1.07) or obese (OR: 0.80; 95 % CI: 0.61,
1.05) was associated with non-significantly lower odds of
ESRD among blacks. On the other hand, whites who were
obese had a 2-fold higher odds (OR: 2.17; 95 % CI: 0.94,
4.98) of ESRD, albeit not statistically significant. The
p-value for interaction term was = 0.03 in adjusted
models, suggesting effect modification by race of the
association between BMI at enrollment and ESRD.
In further analyses subdividing the obese groups, among
whites, odds of ESRD increased with increasing class of
obesity, and those with class III obesity had a significant
greater than 3-fold increased odds (OR: 3.31; 95 % CI:
1.08, 10.12) of ESRD. In contrast, among blacks, those
with class III obesity did not have significantly increased
odds (OR: 1.09; 95 % CI: 0.76, 1.55) of ESRD (Table 3).
Sensitivity analyses
In models additionally adjusted for diabetes and hyperten-
sion, the odds of ESRD remained higher in overweight
and obese persons, and again the associations were more
pronounced among whites, although the strength of the
associations was attenuated (Table 4). Compared to nor-
mal weight individuals, overweight and obese persons had
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a 16 % (OR: 1.16; 95 % CI: 0.89, 1.52) and 82 % (OR: 1.82;
95 % CI: 1.32, 2.51) higher odds of ESRD, respectively. In
stratified models, whites who were overweight or obese
had a 21 % (OR: 1.21; 95 % CI: 0.47, 3.17) and almost 3-
fold (OR: 2.81; 95 % CI: 0.99, 8.02) higher odds of ERSD,
respectively. Among blacks there was an 18 % (OR: 1.18;
Table 1 Baseline characteristics of end-stage renal disease cases and controls in the southern community cohort study
Overall Whites Blacks
Cases Controls P Cases Controls P Cases Controls P
N = 631 N = 1897 66 198 565 1699
Age 53.8 (9.0) 53.7 (9.0) 0.75 56.6 (7.8) 56.7 (7.8) 0.96 53.5 (9.1) 53.3 (9.0) 0.73
Age Categories 1.00 0.77 1.0
40–49 243 (38.5) 730 (38.5) 16 (24.2) 47 (23.7) 227 (40.2) 683 (40.2)
50–59 228 (36.1) 682 (36.0) 30 (45.5) 83 (41.9) 198 (35.0) 599 (35.3)
60–69 124 (19.7) 375 (19.8) 19 (28.8) 60 (30.3) 105 (18.6) 315 (18.5)
70–79 36 (5.7) 110 (5.8) 1 (1.5) 8 (4.0) 35 (6.2) 102 (6.0)
Women 346 (54.8) 1039 (54.8) 0.98 40 (60.6) 120 (60.6) 1.0 306 (54.2) 919 (54.1) 0.98
BMI at age 21 (Kg/m2) <0.0001 <0.0001 <0.0001
Underweight 53 (9.0) 214 (11.8) 2 (3.1) 29 (15.0) 51 (9.7) 185 (11.4)
Normal 291 (49.4) 1101 (60.5) 28 (43.8) 117 (60.6) 263 (50.1) 984 (60.5)
Overweight 131 (22.2) 357 (19.6) 14 (21.9) 33 (17.1) 117 (22.3) 324 (19.9)
Obese class I 66 (11.2) 97 (5.3) 11 (17.2) 8 (4.2) 55 (10.5) 89 (5.5)
Obese class II 26 (4.4) 27 (1.5) 7 (10.9) 4 (2.1) 19 (3.6) 23 (1.4)
Obese class II 22 (3.8) 23 (1.3) 2 (3.1) 2 (1.0) 20 (3.8) 21 (1.3)
BMI at enrollment (Kg/m2) 0.02 0.14 0.03
Underweight 7 (1.1) 14 (0.7) 1 (1.5) 1 (0.5) 6 (1.1) 13 (0.8)
Normal 141 (22.7) 382 (20.3) 11 (16.9) 47 (24.0) 130 (23.4) 335 (19.9)
Overweight 167 (26.9) 553 (29.4) 12 (18.5) 56 (28.6) 155 (27.9) 497 (29.5)
Obese class I 111 (17.9) 431 (22.9) 16 (24.6) 48 (24.5) 95 (17.1) 383 (22.7)
Obese class II 96 (15.5) 271 (14.4) 13 (20.0) 23 (11.7) 83 (15.0) 248 (14.7)
Obese class II 98 (15.8) 230 (12.2) 12 (18.5) 21 (10.7) 86 (15.5) 209 (12.4)
Diabetes 411 (65.1) 539 (28.5) <0.0001 46 (69.7) 43 (21.7) <0.0001 365 (64.6) 496 (29.2) <0.0001
Hypertension 541 (85.7) 1242 (65.5) <0.0001 52 (78.8) 120 (60.6) 0.007 489 (86.5) 1122(66.1) <0.0001
High Total Cholesterol 315 (50.0) 615 (35.3) <0.0001 43 (66.2) 97 (49.2) 0.02 272 (48.1) 568 (33.6) <0.0001
Education 0.78 0.01
< High school 262 (41.5) 718 (37.9) 0.035 24 (36.4) 72 (36.4) 238 (42.1) 646 (38.0)
High school/Vocational
training/Junior college
336 (53.3) 1027 (54.1) 33 (50.0) 105 (53.0) 303 (53.6) 922 (54.3)
College degree
or higher
33 (5.2) 152 (8.0) 9(13.6) 21 (10.6) 24 (4.3) 131 (7.7)
Income <0.0001 0.55 <0.0001
< $15,000 459 (73.7) 1186 (63.1) 48 (72.7) 135 (69.6) 411 (73.8) 1051 (62.4)
$15,000–24,999 111 (17.8) 425 (22.6) 11 (16.7) 28 (14.4) 100 (18.0) 397 (23.6)
≥ $25,0000 53 (8.5) 268 (14.3) 7 (10.6) 31 (16.0) 46 (8.3) 237 (14.1)
Smoking 0.24 0.80 0.14
Never 218 (34.6) 724 (38.2) 21 (31.8) 55 (27.8) 197 (34.9) 669 (39.5)
Former 160 (25.4) 445 (23.5) 19 (28.8) 63 (31.8) 141 (25.0) 382 (22.5)
Current 253 (40.1) 724 (38.2) 26 (39.4) 80 (40.4) 227 (40.2) 644 (38.0)
*P = p-value for univariate comparisons; Data are means (SD) or Frequencies (%)
We used all the data available for each variable to perform the univariate comparisons. We had no missing data for age, race and gender; <1 % missing for BMI at
enrollment, diabetes status, hypertension history, income, education and smoking; and 6.7 % missing for BMI at age 21 in cases and 4.1 % in controls
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Table 2 The association between BMI at age 21 and end-stage renal disease in the southern community cohort study, overall and stratified by race
Overall Whites Blacks
Cases Controls ORa 95 % CI Cases Controls ORa 95 % CI Cases Controls ORa 95 % CI
N = 589 N = 1819 N = 64 N = 193 N = 525 N = 1626
BMI Category
Underweight 53 214 0.89 0.63, 1.25 2 29 0.19 0.02, 1.46 51 185 0.99 0.69, 1.41
Normal 291 1101 1.00 (referent) N/A 28 117 1.00 (referent) N/A 263 984 1.00 (referent) N/A
Overweight 131 357 1.44 1.13, 1.85 14 33 2.13 0.92, 4.93 117 324 1.41 1.09, 1.83
Obese 114 147 2.88 2.16, 3.83 20 14 7.46 2.90, 19.21 94 133 2.56 1.88, 3.47
Abbreviations: BMI Body Mass Index, CI Confidence Interval, OR odds ratio, N/A not applicable
P value for race × continuous BMI interaction term (test for additivity) in adjusted model = 0.05 (in the unadjusted model, the P value = 0.047)
aAdjusted for education (<high school, completed high school, vocational training or junior college and ≥ college degree), and smoking history (never, former and current). Age, gender and race were matching factors














95 % CI: 0.89, 1.57) and 71 % (OR: 1.71; 95 % CI: 1.22,
2.41) higher odds of ESRD in overweight and obese indi-
viduals, respectively (p-value for interaction = 0.29).
In analyses restricted to cases (and their matched con-
trols) with more than 12 months of follow-up, we ob-
served non-significant increased odds for ESRD in
whites in the overweight, and class I and II obesity cat-
egories (compared to the normal weight), and a signifi-
cant 4-fold (OR: 3.99; 95 % CI: 1.11, 14.35) increased
risk for those in the class III obesity category. In con-
trast, there was no increased risk among blacks with
class III obesity (OR: 1.02; 95 % CI: 0.70, 1.52). In add-
itional analyses restricted to cases with more than 2 or
more than 3 years of follow up, the associations with
ESRD in the highest BMI categories were more pro-
nounced, but again the point estimates were substan-
tially higher in whites compared to blacks. In particular,
in the analyses restricted to those with more than 3 years
of follow-up, there was a non-significant 5-fold (OR:
5.04; 95 % CI: 0.32, 79.49) increased odds of ESRD
among whites with class III obesity, as compared to a
corresponding non-significant 45 % (OR: 1.45; 95 % CI:
0.84, 2.51) increased odds of ESRD among blacks (data
not shown).
Discussion
In this case–control study nested within the SCCS co-
hort of low-income blacks and whites, we found that the
association between elevated BMI (both in early adult-
hood and midlife) and ESRD differed by race. Among both
black and whites, being overweight or obese in early adult-
hood (age 21) was associated with a higher risk of ESRD,
but the magnitude of the association was considerably
stronger in whites compared to blacks. Being obese in
Fig. 1 The predicted probabilities of incident ESRD for whites and blacks, plotted against BMI at age 21. BMI at age 21 was modeled using restricted
cubic splines with 5 knots. Predicted probabilities of incident ESRD computed from multivariable logistic models were plotted against BMI at age 21.
There is a monotonic increase in the probability of ESRD after a BMI cutoff≈ 25 kg/m2 in both whites and blacks but the slope of the curve for whites
appears steeper
Akwo et al. BMC Nutrition  (2015) 1:24 Page 6 of 11
Table 3 The association between BMI at enrollment and end-stage renal disease in the southern community cohort study, overall and stratified by race
Overall Whites Blacks
Cases Controls ORa 95 % CI Cases Controls ORa 95 % CI Cases Controls ORa 95 % CI
N = 620 N = 1881 N = 65 N = 196 N = 555 N = 1685
BMI Category
Underweight 7 14 1.27 0.49, 3.28 1 1 3.54 0.18, 69.17 6 13 1.06 0.39, 2.92
Normal 141 382 1.00 N/A 11 47 1.00 (referent) N/A 130 335 1.00 (referent) N/A
Overweight 167 553 0.83 0.64, 1.08 12 56 0.99 0.38, 2.59 155 497 0.81 0.61, 1.07
Obese 305 932 0.89 0.69, 1.14 41 92 2.17 0.94, 4.98 264 840 0.80 0.61, 1.05
Obese I 111 431 0.72 0.53, 0.96 16 48 1.63 0.65, 4.17 95 383 0.65 0.47, 0.88
Obese II 96 271 0.97 0.70, 1.33 13 23 2.62 0.96, 7.12 83 248 0.86 0.61, 1.22
Obese III 98 230 1.21 0.86, 1.69 12 21 3.31 1.08, 10.12 86 209 1.09 0.76, 1.55
Abbreviations: BMI Body Mass Index, CI Confidence Interval, OR odds ratio, N/A not applicable
P value for race × continuous BMI interaction term (test for additivity) in adjusted model = 0.03 (in the unadjusted model, the P value = 0.02)
aAdjusted for education (<high school, completed high school, vocational training or junior college and ≥ college degree)), and smoking history (never, former and current). Age, gender and race were matching factors














Table 4 Sensitivity analysis: the association between BMI at age 21 and end-stage renal disease in the southern community cohort study adjusting for diabetes and hypertension
and stratified by race
Overall Whites Black
Cases Controls ORa 95 % CI Cases Controls ORa 95 % CI Cases Controls ORa 95 % CI
N = 589 N = 1816 N = 64 N = 193 N = 525 N = 1623
BMI Category
Underweight 53 213 0.92 0.63, 1.33 2 29 0.20 0.02, 1.73 51 184 1.01 0.68, 1.48
Normal 291 1100 1.00 (referent) N/A 28 117 1.00 (referent) N/A 263 983 1.00 (referent) N/A
Overweight 131 356 1.16 0.89, 1.52 14 33 1.21 0.47, 3.17 117 323 1.18 0.89, 1.57
Obese 114 147 1.82 1.32, 2.51 20 14 2.81 0.99, 8.02 94 133 1.71 1.22, 2.41
Abbreviations: BMI Body Mass Index, CI Confidence Interval, OR odds ratio, N/A not applicable
aAdjusted for education (<high school, completed high school, vocational training or junior college and ≥ college degree), smoking history (never, former and current), diabetes and hypertension. Age, gender and race














midlife (mean age at enrollment was 53.7 years) was not
associated with increased risk of ESRD among blacks,
while among whites a significantly increased risk of ESRD
was observed only among those in the highest category of
obesity (BMI ≥ 40).
A few studies have previously reported increased risk of
ESRD with higher BMI in early adulthood or adolescence.
Using data from over 1.2 million adolescents who under-
went fitness evaluation for the Israeli military, Vivante and
colleagues reported hazard ratios 3.00 (95 % CI: 2.50–3.60)
and 6.89 (95 % CI: 5.52–8.59) for ESRD among those who
were overweight or obese, respectively, over a 25-year
follow-up period [9]. A retrospective Swedish study of 926
cases and 998 controls observed a 3-fold increased odds
(OR 3.1, 95 % CI: 2.1–4.8) of chronic renal insufficiency
among persons who were overweight at age 20 [5]. Silver-
wood et al. also reported an association between younger
age when first overweight and other overt renal outcomes
using data from the UK Medical Research Council Na-
tional Survey [26]. In particular, those who first became
overweight in early adulthood (26 or 36 years) had in-
creased risk of developing stage 3 chronic kidney disease
(CKD) in later life [26]. Similarly, children who were over-
weight in early life (2–20 years) had increased odds of de-
veloping CKD compared to those who were never
overweight [27]. These prior studies involved predomin-
antly white populations, and our findings for BMI at age
21 among whites are consistent with those results. How-
ever, ours is the first study to investigate this association
among blacks, who are at highest risk for ESRD, and to
specifically test for effect modification by race, with sub-
stantially more pronounced associations among whites
compared to blacks.
For BMI in middle-age, a number of studies in various
populations, primarily Asian and Caucasian, have re-
ported greater than two-fold increased risks of ESRD in
overweight or obese individuals [5, 6]. To our knowledge,
the study by Hsu and colleagues using data for 320,252
adults (18 % black, 69 % white) and 1,427 ESRD cases
from Kaiser Permanente is the only study that investigated
potential heterogeneity of the BMI-ESRD relationship in
middle-aged blacks and whites. They reported that among
blacks, when compared to persons with normal weight, in-
dividuals with obesity class II and III had a risk ratio of 5.5
(95 % CI: 4.1–7.5) and 7.2 (95 % CI: 5.0–10.4), respectively;
among whites, corresponding risk ratios were 7.2 (95 % CI:
5.2–10.0) and 8.0 (95 % CI: 5.0–12.8) [8]. A major differ-
ence between the two studies is the duration of follow up,
being relatively short (median ~ 2.6 years) in our investiga-
tion compared to that of the Kaiser study (~26 years).
Thus, with longer follow-up, it is possible that our results
may be more similar, as suggested by our findings of a
strong link between ESRD and BMI at age 21 and by our
sensitivity analyses hinting at stronger associations of
ESRD with middle age BMI among those with longer fol-
low up. Also, differences in socioeconomic status be-
tween blacks and whites are likely to be more
pronounced in the Kaiser population than in our
study population, and thus residual confounding may
contribute to the elevated ESRD risk associated with
BMI among blacks.
As ESRD and cardiovascular disease (CVD) share risk
factors including obesity, one could expect similar racial
patterns in BMI-ESRD and BMI-CVD relationships. Previ-
ous studies have reported stronger associations between
BMI and cardiovascular outcomes in whites compared to
blacks [28, 29]. In the SCCS cohort, it has previously been
shown that whites with class III obesity had a greater than
2-fold increased risk of cardiovascular death compared to
those of normal weight, while in blacks the increase in risk
was modest (17–40 %) and non-significant [29]. Similarly,
using SCCS data, Lipworth et al. found that in whites the
HR for atrial fibrillation was 1.49 (95 % CI: 1.11, 2.01) in
obese persons (compared to normal weight persons), while
among blacks the corresponding HR was 0.90 (95 % CI:
0.69, 1.16) [30]. Our findings, which suggest a stronger
BMI-ESRD association in whites compared to blacks, are
thus in line with CVD results in the same cohort.
The underlying reasons for these differential relationships
by race remain poorly understood. It is well-established
that blacks and whites have different body compositions,
whereby on average whites have higher visceral fat and per-
cent body fat than blacks at equivalent BMI [18, 31]. Waist
circumference may be a better proxy than BMI for visceral
adiposity [32], which is central to the pathophysiology of
cardiorenal endpoints. Waist circumference was measured
for only about 10 % of SCCS participants, and in the
current analysis was available for only 16 ESRD cases and
54 controls. Among whites, waist circumferences was
higher (123.3 vs 101.1 cm) in cases (n = 4) compared to
controls (n = 13), while amongst blacks it was similar (103.3
vs 107.7 cm) in cases (n = 12) and controls (n = 41). While
caution is mandatory given the small numbers, these data
lend some support to the hypothesis that there may be a
differential association between obesity and ESRD by race.
Waist circumference was previously shown to be more
strongly associated with all-cause mortality in whites com-
pared to blacks [20], raising the possibility that higher adi-
posity may have less detrimental health effects in blacks
compared to whites. The existence of such differential ef-
fects and its potential link to differences in metabolic path-
ways related to inflammation and insulin resistance or
gene-environment interactions remains to be explored. Pre-
vious studies in the SCCS have also revealed differences in
mean levels of BMI-related biomarkers (including adipo-
nectin, leptin, insulin-like growth factor 1, and C-reactive
protein) between blacks and whites and in the magnitude
of associations of these biomarkers with BMI [19–22],
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providing additional evidence that biological mechanisms
associated with obesity may differ across racial groups.
The SCCS provides a unique opportunity to examine
health disparities for a sizeable number of black partici-
pants, who have traditionally been under-represented in
most studies focused on cardio-renal outcomes. In addition,
both black and white participants had similar income and
education levels thereby minimizing confounding by socio-
economic differences; and a high burden of obesity and its
comorbidities (diabetes and hypertension). Linkage of the
cohort with the USRDS ensured near complete and un-
biased ascertainment of ESRD cases. The prospective na-
ture of the nested case–control study design minimized
reporting bias on the part of the subjects related to know-
ing their disease status. Limitations of the study included
our reliance on self-reported height and weight for calcula-
tion of BMI at enrollment, but a prior validation study for a
subset (n = 14,000) of SCCS participants for whom weight
and height were abstracted from contemporaneous clinic
records showed very high correlation (r >0.95) between
self-reported and measured weight and height [29]. Data
from the National Health and Nutrition Examination Sur-
vey also suggest that BMI based on self-report has good
agreement with BMI from measured values [33]. Also, data
for weight at age 21 is prone to recall bias which is likely
non-differential as data collection was done at baseline be-
fore ascertainment of ESRD. Additionally, there may be
some variation in BMI throughout early adulthood which a
singular value of BMI at age 21 may not completely cap-
ture. The limited number of cases among whites curtailed
the power of the analyses in this group so we advise some
caution in interpreting these results.
Conclusions
In summary, we observed marked racial differences in
the relationship between BMI, particularly BMI in early
adulthood, and ESRD in a low-income population with a
high burden of obesity. This should prompt more re-
search into understanding the underlying metabolic and
potential gene-BMI interactions over the lifespan that
may explain these differences and which may add to the
body of evidence needed to tailor strategies to combat
the deleterious effects of obesity.
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